Portugal, Feb. 2 -- Portugal based Fresenius Kabi Pharma Portugal, Lda. has secured contract from Instituto Portugues De Oncologia Do Porto Francisco Gentil, Epe for Adcm 4944/25 - Clinical Consumption Material. The value of the contract is worth 651000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....